18 hrs ago | PR-inside.com
GlaxoSmithKline plc - PharmaVitae Profile - New Research Report on Companies and Markets
The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Adolor Provides Update On Entereg (alvimopan) Obd Program - Fda Lifts Clinical Hold On Obd Ind
Main Category: GastroIntestinal / Gastroenterology Also Included In: Clinical Trials / Drug Trials Adolor Corporation today issued an update on the Entereg Program for chronic opioid bowel dysfunction , under ...
GSK, Novartis plan to appeal verdict
Two large pharmaceutical companies said Thursday they will appeal a jury verdict ordering them to pay more than $114 million for overcharging the state's Medicaid program for prescription drugs.
GSK Does Not Expect FDA Approval Of HPV Vaccine Cervarix Until End Of 2009
Main Category: Cervical Cancer / HPV Vaccine Also Included In: Regulatory Affairs / Drug Approvals Article Date: 03 Jul 2008 GlaxoSmithKline on Monday said it does not expect to receive FDA approval for its ...
GlaxoSmithKline plc (GSK): Bill Nygren Initiates Holdings in GSK
GuruFocus Home >> Stock Ideas >> Recent Picks >> Glaxosmithkline Plc GSK - GlaxoSmithKline plc $117.2 Bil 18.69% 52.22% 6.3 33.19% 2.58 23.01% 4.94% $0 2664.26 Mil GlaxoSmithKline is one of the world's leading ...
2 firms to appeal $114M verdict in drug case
Drug companies GlaxoSmithKline and Novartis say they will appeal a jury verdict ordering them to pay more than $114 million to Alavbama for overcharging the state's Medicaid program for prescription drugs.
Long-Term Study Of Middle-Aged Mice Shows Resveratrol...
Main Category: Diabetes Also Included In: Cardiovascular / Cardiology Article Date: 03 Jul 2008 - 13:00 PDT Sirtris, a GlaxoSmithKline company focused on discovering and developing small molecule drugs to treat ...
Main Category: Medicare / Medicaid / SCHIP Also Included In: Pharma Industry / Biotech Industry ; Medical Malpractice / Litigation Article Date: 03 Jul 2008 - 6:00 PDT An Alabama state court jury on Tuesday ...
Adolor Provides Update on Entereg (alvimopan) OBD Program
Jul 3, 2008 - Adolor Corporation today issued an update on the Entereg Program for chronic opioid bowel dysfunction , under development in collaboration with GlaxoSmithKline .
FDA panel urges more testing for diabetes drugs
By MATTHEW PERRONE The Associated Press Wednesday, July 2, 2008; 4:31 PM WASHINGTON -- Diabetes drugs would be subject to more stringent safety standards that could cost manufacturers millions, under ...
A Drug to End Merck's Headache?
But Merck was able to relieve some of those headaches on Friday by presenting pretty good data for its phase 3 migraine drug, telcagepant.
Genmab Reaches Milestone In Ofatumumab Collaboration
Genmab said Monday it has reached a development milestone for ofatumumab under the terms of its collaboration with GlaxoSmithKline .
Jury Favors Alabama in Drug Suit
A jury in Montgomery County Circuit Court returned a verdict in favor of the State of Alabama, finding defendants, GlaxoSmithKline and Novartis Pharmaceuticals Corp.
Smoking ban triggered the biggest fall in smoking ever seen in England
Smokefree law in England has helped more smokers to quit than ever before and will help prevent an estimated 40,000 deaths over the next 10 years - according to new research being presented in Birmingham ...
Exelixis, Inc. and GlaxoSmithKline Agree to Successfully Conclude...
Exelixis, Inc. announced today that the company and GlaxoSmithKline, Inc. will bring their six-year collaboration to a successful conclusion on October 27, 2008, as scheduled.
Ala. lawyer asks jury for $800M in drug fraud case
An attorney for Alabama asked jurors Monday to award the state as much as $800 million from two pharmaceutical companies accused of overcharging for Medicaid drugs.
GlaxoSmithKline sets date for data on key drug
GlaxoSmithKline expects to submit new data on its cervical-cancer vaccine, Cervarix, in the first half of 2009, the company said Monday.
Gates-backed vaccine investor eyes HPV and rubella
GENEVA - An international partnership that funds vaccines for children in poor countries will decide on Wednesday whether to also start investing in vaccinations to protect adult women.The ...
Panel endorses new combo vaccines for children
ATLANTA - A federal advisory panel yesterday endorsed two new combination vaccines designed to reduce the number of jabs young children must endure to get the recommended immunizations.
Exelixis, GlaxoSmithKline collaboration ending
A collaboration between Exelixis Inc. and GlaxoSmithKline will conclude at the end of October.